| [1] Kraft E M. Integrated test and evaluation: a knowledge-based approach to system development, AIAA-1995-3982[R]. Reston: AIAA, 1995.[2] Waters D P. Integrating modeling and simulation with test and evaluation activities, AIAA-2004-6800[R]. Reston: AIAA, 2004.[3] Claxton J D, Cavoli C, Johnson C. Test and evaluation management guide[M]. 6th ed. Fort Belvoir, VA: The Defense Acquisition University Press, 2012: 311.[4] Adcock C J. Sample size determination: a review[J]. Journal of the Royal Statistical Society: Series D (The Statistician), 1997, 46(2): 261-283.[5] Murphy K R, Myors B, Wolach A H. Statistical power analysis: a simple and general model for traditional and modern hypothesis tests[M]. 3rd ed. New York: Routledge, 2009: 224.[6] Balci O. Verification, validation and accreditation of simulation models[C]//Proceedings of the 1997 Winter Simulation Conference. Piscataway, NJ: IEEE, 1997: 135-141.[7] Rebba R, Mahadevan S, Huang S P. Validation and error estimation of computational models[J]. Reliability Engineering & System Safety, 2006, 91(10-11): 1390-1397.[8] Balci O. Verification, validation, and testing of models[M]. New York: Springer, 2013: 1618-1627.[9] De Santis F. Using historical data for Bayesian sample size determination[J]. Journal of the Royal Statistical Society: Series A (Statistics in Society), 2007, 170(1): 95-113.[10] Ibrahim J G, Chen M H. Power prior distributions for regression models[J]. Statistical Science, 2000, 15(1): 46-60.[11] Desu M M, Raghavarao D. Sample size methodology[M]. Boston, MA: Academic Press, 1990.[12] Joseph L, Wolfson D B, Du Berger R. Sample size calculations for binomial proportions via highest posterior density intervals[J]. The Statistician, 1995, 44(2): 143-154.[13] Joseph L, Belisle P. Bayesian sample size determination for normal means and differences between normal means[J]. Journal of the Royal Statistical Society: Series D (The Statistician), 1997, 46(2): 209-226.[14] Di Bacco M, Amore G D, Scalfari F, et al. Two experimental settings in clinical trials: predictive criteria for choosing the sample size in interval estimation[M]. Norwell, MA: Springer, 2004: 109-130.[15] Greenhouse J B, Waserman L. Robust Bayesian methods for monitoring clinical trials[J]. Statistics in Medicine, 1995, 14(12): 1379-1391.[16] Fryback D G, Chinnis J O, Ulvila J W. Bayesian cost-effectiveness analysis[J]. International Journal of Technology Assessment in Health Care, 2001, 17(1): 83-97.[17] Duan Y. A modified Bayesian power prior approach with applications in water quality evaluation[D]. Blacksburg, Virginia: Virginia Polytechnic Institute and State University, 2005.[18] Spiegelhalter D J, Abrams K R, Myles J P. Bayesian approaches to clinical trials and health-care evaluation[M]. Chichester, West Sussex: John Wiley & Sons, 2004: 406.[19] De Santis F. Power priors and their use in clinical trials[J]. The American Statistician, 2006, 60(2): 122-129.[20] Muessig P R, Laack D R, Wrobleski J J. An integrated approach to evaluating simulation credibility, ADA405051[R]. California: Naval Air Warfare Center Weapons, 2001.[21] Yang H Z, Kang F J, Yan J T. A methodology of simulation credibility evaluation based on AHP[J]. Journal of System Simulation, 2006, 18(s2): 52-54 (in Chinese). 杨惠珍, 康凤举, 阎晋屯. 一种基于AHP的仿真可信度评估方法研究[J]. 系统仿真学报, 2006, 18(s2): 52-54.[22] Fang K, Ma P, Yang M. AHP ultra weight for simulation credibility evaluation[J]. Journal of Beijing University of Aeronautics and Astronautics, 2011, 37(5): 584-588 (in Chinese). 方可, 马萍, 杨明. 仿真可信度评估中的AHP超越权重[J]. 北京航空航天大学学报, 2011, 37(5): 584-588.[23] Jiao P. Research on the VV & A theory and method of missile guidance simulation system[D]. Changsha: National University of Defense Technology, 2010 (in Chinese). 焦鹏. 导弹制导仿真系统VV&A理论和方法研究[D]. 长沙: 国防科学技术大学, 2010.[24] Bernardo J M, Smith A F M. Bayesian theory[M]. New York: John Wiley & Sons, 2000: 608. |
CJA
